Nike hopes its newest running shoe will help athletes improve their performance, and the company’s vice president of running footwear credits the way the sneaker is manufactured with helping achieve that goal.
“We use computational design, which is informing this pattern that you see on the midsole and outsole, so that’s called our fluid geometry” said Brett Holts in an interview with Cheddar. “What this allows us to do is iterate much quicker.”
“We can take thousands of data inputs from elite athletes, every day runners, our research lab. We can put all those inputs into a computer program, and it spits out an algorithm that gives us this fluid geometry.”
But the competition is heating up. Last year Adidas, which touts its own BOOST technology, overtook Nike’s Michael Jordan-fronted line as the #2 brand in U.S. sports footwear.
Holts, though, isn’t intimidated.
“We feel like [competition] continues to push us, continues to keep us sharp,” he said.
The Nike Epic React Flyknit will be available on February 22 and cost $150.
For full interview [click here](https://cheddar.com/videos/inside-nikes-newest-innovation).
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
StellerFi debt forgiveness.
